Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial

research Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial

25 citations , December 2017 in “The Journal of Clinical Endocrinology & Metabolism”

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

research 76221 Faster Onset and Superior Efficacy of an Investigational Extended-Release Oral Minoxidil Tablet (VDPHL01) Versus Topical and Immediate-Release Oral Minoxidil for Androgenetic Alopecia: Results from a Blinded Retrospective Investigator Global Assessment

July 2026 in “Journal of the American Academy of Dermatology”

research Side effects of CHOP in the treatment of non-Hodgkin's lymphoma

46 citations , December 1997 in “Cancer Nursing”

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

research The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders

57 citations , January 1995 in “The American journal of medicine”

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

research Androgenic alopecia in postmenopausal ovarian hyperthecosis

1 citations , May 2011 in “Journal of Obstetrics and Gynaecology”

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

research [Androgenetic alopecia].

January 1997 in “PubMed”

Androgenetic Alopecia Incidence in Transgender and Gender Diverse Patients on Hormone Therapy Compared to Cisgender Patients

research 42017 Androgenetic Alopecia Incidence in Transgender and Gender Diverse Patients on Hormone Therapy Compared to Cisgender Patients

September 2023 in “Journal of The American Academy of Dermatology”

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

← Previous page